New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
Early detection and thus rapid therapy of cardiotoxicity related to chemotherapy are essential for restoring cardiovascular function. The complete recovery of the cardiovascular system decreases with time to identify the presence of cardiotoxic damage. The project aims to define new biomarkers for the early detection of cardiotoxicity in patients treated with chemotherapy.
The most effective approach to minimizing the consequences of cardiotoxicity of oncological treatment is its early identification, adjustment of oncological treatment (change of procedure, dose, drugs), and immediate initiation of cardiovascular therapy. However, the current standard for monitoring the cardiovascular system in cancer patients identifies cardiotoxicity only if functional impairment has already occurred, which precludes any chance of effective prevention. The aim of the project is to identify new biomarkers for the early detection of the cardiotoxic effect of chemotherapy in women with breast cancer.
Inclusion Criteria:
Exclusion Criteria:
robert.petr81@gmail.com+420 233 336 334
renata.kozevnikovova@onko-centrum.cz+420222501403